Clinical Trial Update: Effects and Safety of Liposome Encapsulated Botulinum Toxin A for Overactive Bladder Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and effects of liposome-encapsulated botulinum toxin A for Overactive Bladder; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Liposome-Encapsulated Botulinum Toxin A (Botulinum toxin type A)

Snippet

Sponsor: Buddhist Tzu Chi General Hospital | Conditions: Overactive Bladder | Phase 2 | Status: COMPLETED | Results posted: 2014-09-22